isoniazid has been researched along with alpha-aminopyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordes, HP; Schaper, KJ; Seydel, JK; Wempe, E | 1 |
| Ahidjo, BA; Bishai, WR; Maiga, M; Maiga, MC | 1 |
2 other study(ies) available for isoniazid and alpha-aminopyridine
| Article | Year |
|---|---|
Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
Topics: Antitubercular Agents; Isoniazid; Kinetics; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Regression Analysis; Structure-Activity Relationship | 1976 |
Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis.
Topics: Aminopyridines; Animals; Antitubercular Agents; Benzamides; Cyclopropanes; Disease Models, Animal; Female; Interferon-gamma; Interleukin-1beta; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phosphodiesterase 4 Inhibitors; Survival Analysis; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2015 |